Where MedTech professionals gain clarity and confidence to navigate complex decisions.
Let's Talk Risk! Podcast
Let’s Talk Risk! brings together MedTech leaders and practitioners for thoughtful conversations on the challenges that shape risk, quality, innovation, and leadership. With 150+ episodes and more than 30K downloads, it helps professionals gain the clarity and confidence to lead through complex decisions. naveenagarwalphd.substack.com
Be sure to visit the podcast's website and support the creator: naveenagarwalphd.substack.com
Author
Where MedTech professionals gain clarity and confidence to navigate complex decisions.
Category
Podcast website
Latest episode
Nov 12, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
LTR 44: Why we need a new approach to learning medical software and medical AI 22.03.2024 34:18
Artificial intelligence (AI) is rapidly unlocking new applications in the medical arena. It is challenging to keep up with something moving so fast. ChatGPT was launched just a couple of years ago, and we are already talking about artificial general intelligence (AGI) for medical purposes! In this Let’s Talk Risk! conversation, Prof. Papademetris shares that indeed we are in a new game with plenty...
RM roundup #2: 10 noteworthy risk-related LinkedIn posts 14.03.2024 20:43
Listen to my reading of a recent LinkedIn article I published to cover 10 noteworthy risk-related posts recently published on LinkedIn. Listen to the recording and follow links below to read the original posts and continue the conversation. 🗞️A roundup of 10 noteworthy risk-related posts on LinkedIn! 1️⃣ Randy Horton spotlights top 10 Health Technology Hazards for 2024 compiled by ECRI. 2️⃣ Marco...
LTR 43: Tips for integrating risk analysis with design controls 08.03.2024 38:14
One of the key requirements of ISO 13485, the International Standard for medical device Quality Management Systems is establish a link between risk management and the design and development process. In practice this proves to be quite challenging. In this Let’s Talk Risk! conversation, Chuck Ventura shares that medical device design and development process is a chaotic process. Design controls sho...
RM roundup #1: 10 of my favorite risk-related LinkedIn posts 01.03.2024 20:58
Listen to my reading of a recent LinkedIn article I published to cover 10 of my favorite LinkedIn posts on risk-related topics. Listen to the recording and follow links below to read the original posts and continue the conversation. 🗞️A roundup of my favorite risk-related posts on LinkedIn! 1️⃣ Bryan Whitefield says the job of a risk practitioner is to uncover the elephant in the room! Read the or...
LTR 42: State or event? Thinking clearly about hazards will help you manage risk. 23.02.2024 33:55
We have been used to treating the term hazard as a potential source of harm. We are also familiar with the concept of exposure to hazard in a hazardous situation as a necessary condition for harm to occur. The question, often left unanswered, is whether the duration of exposure has any effect on the type and severity of harm experienced by the user/patient. In this insightful conversation, James C...
LTR 40: A guest podcast with NAMSA - Part 1 16.02.2024 42:01
Recently, I was invited by Richard Granquist and Linford Leitch from NAMSA to talk about risk management as part of their monthly RA QA Cafe podcast. In part 1 of a 2 part series, we discussed the following topics in a very open and engaging conversation! * How I got into risk management. * How I think about risk management in a small vs. large organization. * Why risk management is not a paper ex...
LTR 39: Overcoming challenges in linking risk management with design controls 09.02.2024 33:19
A common challenge for risk practitioners in the medical device industry is to efficiently link their risk management process with the design controls process. The output of risk management activities needs to be linked to the design process before design inputs are finalized. However, this proves to be quite challenging in practice. One reason is that a lot of work in the industry is often done i...
LTR 38: How medical safety professionals can serve as culture brokers in MedTech 02.02.2024 34:58
Who is responsible for patient safety in a medical device manufacturing organization? When asked this question, a common response is likely to be that it is a shared responsibility across the entire organization. After all, everyone should be thinking about patient safety in their specific role and perform their duties such that patient safety is not compromised. It is true that no single individu...
LTR 36: Why we should not overlook the quality-of-life benefit in risk evaluation 19.01.2024 33:39
When it comes to medical devices, we generally think about only clinical benefits as we plan our clinical investigations to generate scientific evidence for demonstrating safety and effectiveness. However, medical devices also provide many other quality-of life-benefits that are often overlooked during benefit-risk evaluation. One reason is that these benefits are often subjectively experienced by...
LTR Weekly Digest #19 - 13th January, 2024 13.01.2024 3:25
Dear colleagues, hello! 👋 A special welcome to 75+ new members who have joined our Let’s Talk Risk! community this month! Feel free to browse past articles in the archive section of the Let’s Talk Risk! website , and check out recordings of recent LTR conversations in the podcast section. Check out these recent articles published last week on LTR ➡️The upcoming Quality Management System Regulatio...
LTR 35: Tips for improving collaboration in risk management 12.01.2024 34:29
The practice of risk management in a heavily regulated industry such as medical devices is hard. There are many challenging questions that must be resolved in a simple way that is both sensible and defensible to demonstrate compliance with regulatory requirements. Questions such as how should we e stimate P1 and P2 for each risk? How do analyze benefit vs. risk ? How do we analyze risks associated...
LTR Weekly Digest #18 - 6th January, 2024 06.01.2024 3:23
Dear colleagues, hello! 👋 Happy New Year to you! I am super excited to continue our work here on Let’s Talk Risk! (LTR) with the single-minded focus on helping all of us achieve success in risk management. Our industry is going through a major transition, with rapidly advancing technology and evolving regulatory landscape across the globe. That is why it is even more important now to support the...
LTR 34: Build a culture of Quality to achieve inspection-readiness at all times 05.01.2024 32:44
The news of an FDA investigator showing up unannounced at a medical device manufacturing facility generally sends a wave of panic throughout the organization! Even when it is a planned inspection, or an audit visit from a notified body, there is a high level of stress before, during and after the inspection. A lot of effort is spent in “getting ready” for the inspection or the audit, documentation...
LTR 33: AI and the future of work for QA/RA professionals 22.12.2023 38:00
Artificial Intelligence (AI) now affects almost every aspect of our personal and professional life. It is also changing the way we work, especially in the knowledge industry. According to a recent report from McKinsey Global Institute about the generative AI and the future of work, 30% of the hours worked in many professional activities across the US economy could be automated by 2030. But AI will...
LTR 32: A new paradigm for building connected medical devices 15.12.2023 35:19
Rapid advancement in digital technologies and cloud computing offer huge opportunities for medical devices, but they are also forcing us to change our approach to design, development and risk management. In this high energy Let’s Talk Risk! conversation Randy Horton inspires us to take a risk-based approach when building and managing connected devices. Historically, we have considered medical devi...
LTR 31: Focus on the purpose to measure process effectiveness 08.12.2023 33:36
The increasing adoption of Medical Device Single Audit Program (MDSAP) has led to a major shift in current auditing practices in the medical device industry. MDSAP has forced auditors to apply a process-based audit approach rather than a checklist-based approach. The focus in a process-based audit is on process effectiveness and not just element-by-element compliance with regulatory requirements....
LTR 30: It is time to unfake risk management! 01.12.2023 35:05
When we practice risk management mainly for the purpose of compliance, we are really faking it! A compliance-focused approach to risk management only leads to an ever increasing number of complex procedures, rules and documentation rather than nurturing a culture of empowerment and customer focus. Risk management in such an environment becomes a check-the-box exercise. In this episode, Vilma Naste...
LTR 29: Challenges and opportunities for digital technologies in medical applications 17.11.2023 31:41
Digital technologies are being rapidly deployed in medical applications. Buzzwords such as AI/ML, SaMD and Digital Therapeutics are fast becoming a part of our vocabulary in the medical device and the broader healthcare space. While there is new excitement about the potential to solve some of our most challenging medical problems, there is also a lot of uncertainty in the regulatory approach to de...
LTR 28: It is time to build equity in medical device design control 10.11.2023 36:54
If the US FDA has approved or cleared a medical device as safe and effective, you would expect it to be equally effective across the entire patient population within the scope of its intended use. Well, you may be surprised to learn that current industry practices in design, development, and testing of medical devices inadvertently introduce many inherent biases in these devices that can lead to p...
LTR 27: Practicable or not, that's the question for risk control 27.10.2023 34:05
The term practicable is used in ISO 14971, the International Standard for application of risk management to medical devices, in the context of risk controls and benefit-risk analysis of an individual residual risk. In practice, this “term” causes a lot of confusion! One source of this confusion appears to stem from the fact that the standards uses the “term” practicable as part of a requirement, b...
LTR 26: Seek clinical input early in development to achieve market success later 20.10.2023 35:50
Why do many medical devices fail to reach their adoption goal after launch? Or, hit roadblocks during the regulatory review process before launch? In this episode, Sara Vazda shares that one reason why medical device manufacturers struggle to achieve their business goals is that clinical input is generally not a natural part of the design and development (D&D) process. Medical device D&D is genera...
LTR 25: Career tip - learn to effectively communicate regulatory risk in business terms 13.10.2023 35:37
M&A has traditionally been a strong driver of revenue growth for medical device companies. The current M&A environment, however, is very challenging for companies because of several factors, including declining capital funding and falling market valuations. In this environment, QA/RA professionals have a unique opportunity to make an impact in their organizations, advises Steve Silverman. Quality...
LTR 24: Clinical evaluation is a lifecycle process, not a one-time activity 06.10.2023 34:15
The current medical device regulation in the European Union (EU-MDR) includes the term clinical evaluation more than 140 times! Clearly, clinical evaluation is now more important than ever under EU-MDR (and IVDR). As a result, a general feeling in the medical device industry is that it is now significantly more challenging to bring innovative new devices to market. Sarah Panten advises practitione...
LTR 23: Focus on intended use in the clinical environment for risk management of IVDs 29.09.2023 32:06
At first glance, risk management of diagnostic devices, including in-vitro devices (IVD), is not overly complex. After all, you mostly have to consider the effects of false negative results, false positive results, and invalid or delayed results. However, it can be challenging to correctly assign the severity of harm(s) resulting from inaccurate and/or delayed results if we don’t fully understand...
Ep 22: Think of post-market surveillance as a value adding business process 22.09.2023 33:42
We often think of the post-market surveillance (PMS) process as a regulatory requirement for medical devices, especially because of the revised EU-MDR (and IVDR) regulations now in effect in the European Union. But it is more than compliance. According to Per Maegaard, PMS is not just an exercise in meeting regulatory requirements, but intelligence gathering that can help other functions including...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.